Deutsch English Français

Contact

EP0814090

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP0814090

EP0814090 - Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 18.05.2001 Database last updated on 11.04.2026
Most recent event Tooltip	18.05.2001	Application deemed to be withdrawn	published on 04.07.2001 [2001/27]
Applicant(s)	For all designated states SYNTELLO INC Suite 310, 4350 Executive Drive San Diego, CA 92121 / US
	[1997/52]
Inventor(s)	01 / Svennerholm, Bo Jakobsdalsgatan 48 412 68 Göteborg / SE
	02 / Rymo, Lars Hällekullavägen 17 430 80 Hovas / SE
	03 / Horal, Peter Orangeriegatan 21 B 412 66 Göteborg / SE
	04 / Jeansson, Stig Föreningsgatan 33 411 27 Göteborg / SE
	05 / Vahlne, Anders Igelkottsstigen 14A 430 80 Hovas / SE
	[1997/52]
Representative(s)	Weller, Wolfgang, et al Witte, Weller, Gahlert, Otten & Steil Patentanwälte Rotebühlstrasse 121 70178 Stuttgart / DE
	[N/P]
Former [1997/52]	Weller, Wolfgang, Dr.rer.nat., et al Witte, Weller, Gahlert, Otten & Steil, Patentanwälte, Rotebühlstrasse 121 70178 Stuttgart / DE
Application number, filing date	97103408.7	12.06.1990
	[1997/52]
Priority number, date	SE19890002148	13.06.1989 Original published format: SE 8902148
	[1997/52]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP0814090
	Date:	29.12.1997
	Language:	EN
	[1997/52]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	16.10.1997
Classification	IPC:	C07K14/15, G01N33/569, G01N33/68, A61K39/21	[1997/52]
	CPC:	C07K14/005 (EP); C07K14/00 (KR); A61K39/00 (EP,KR,US); C12N2740/14022 (EP)
Designated contracting states	ES, FR, IT [1998/04]
Former [1997/52]	AT, BE, CH, DE, DK, ES, FR, GB, IT, LI, LU, NL, SE
Title	German:	Peptide und Antikörper die davon abgeleitet sind zur Diagnose von, Therapie und Impfung gegen HTLV-1 Infektionen	[1997/52]
	English:	Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection	[1997/52]
	French:	Peptides et anticorps dérivés pour le diagnose, la thérapie des, et la vaccination contre des infections de HTLV-1	[1997/52]
Examination procedure	02.04.1997	Loss of particular rights, legal effect: designated state(s)
	27.08.1997	Despatch of communication of loss of particular rights: designated state(s) AT, BE, CH, DE, DK, GB, LI, LU, NL, SE
	12.06.1998	Examination requested [1998/33]
	03.01.2001	Application deemed to be withdrawn, date of legal effect [2001/27]
	25.01.2001	Despatch of a communication from the examining division (Time limit: M04)
	29.01.2001	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2001/27]
Fees paid	Renewal fee
	12.03.1997	Renewal fee patent year 03
	12.03.1997	Renewal fee patent year 04
	12.03.1997	Renewal fee patent year 05
	12.03.1997	Renewal fee patent year 06
	12.03.1997	Renewal fee patent year 07
	14.06.1997	Renewal fee patent year 08
	26.05.1998	Renewal fee patent year 09
	21.05.1999	Renewal fee patent year 10
	Penalty fee
	Penalty fee Rule 85a EPC 1973
	23.06.1997	AT M01 Not yet paid
	26.06.1997	BE M01 Not yet paid
	26.06.1997	CH M01 Not yet paid
	26.06.1997	DE M01 Not yet paid
	26.06.1997	DK M01 Not yet paid
	26.06.1997	GB M01 Not yet paid
	26.06.1997	LU M01 Not yet paid
	26.06.1997	NL M01 Not yet paid
	16.06.1997	SE M01 Not yet paid
	Additional fee for renewal fee
	30.06.2000	11 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X] T. PALKER ET AL.: "Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.", THE JOURNAL OF IMMUNOLOGY, vol. 142, no. 3, 1 February 1989 (1989-02-01), BALTIMORE, MD, USA, pages 971 - 978, XP000268575 [X] 1-5 * abstract * * table 1 *
		[X] T. COPELAND ET AL.: "Envelope proteins of human T cell leukemia virus type I: Characterization by antisera to synthetic peptides and identification of a natural epitope.", THE JOURNAL OF IMMUNOLOGY, vol. 137, no. 9, 1 November 1986 (1986-11-01), BALTIMORE, MD, USA, pages 2945 - 2951, XP002042559 [X] 1-5 * abstract *
		[PX] A. KURATA ET AL.: "Immunodominant sites of human T cell lymphotropic virus type I envelope protein for murine helper T cells.", THE JOURNAL OF IMMUNOLOGY, vol. 143, no. 6, 15 September 1989 (1989-09-15), BALTIMORE, MD, USA, pages 2024 - 2030, XP002042560 [PX] 1-5,7,8 * abstract * * table 1 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.